Group by:
Date |
Item TypeArticle
Severe thrombocytopenia in a patient with metastatic renal cell carcinoma.
Floercken, A., Loew, A., Koch, M., Gebauer, B., Doerken, B. and Riess, H.
Onkologie 32
(11): 670-672.
November 2009
Second-line therapy in refractory pancreatic cancer. results of a phase II study.
Pelzer, U., Stieler, J., Roll, L., Hilbig, A., Doerken, B., Riess, H. and Oettle, H.
Onkologie 32
(3): 99-102.
March 2009
Therapie des Magenkarzinoms [Treatment of gastric cancer].
Lordick, F., Ridwelski, K., Al-Batran, S.E., Trarbach, T., Schlag, P.M. and Piso, P.
Onkologie 31
(Suppl 5): 32-39.
November 2008
Multimodale Therapie des Rektumkarzinoms [Multimodality treatment for colorectal cancer].
Roedel, C., Hoehler, T., Sauer, R., Siewczynski, R., Flentje, M., Budach, V. and Schlag, P.M.
Onkologie 31
(Suppl 5): 24-28.
November 2008
Praeklinische Daten als Grundlage fuer die Konzeption klinischer Studien [Preclinical data as basis for the design of clinical studies].
Fichtner, I.
Onkologie 31
(Suppl. 2): 34-38.
May 2008
Response to Preoperative short-course radiotherapy in locally advanced rectal cancer: Value of F-fluorodeoxyglucose positron emission tomography.
Siegel, R., Dresel, S., Koswig, S., Gebauer, B., Huenerbein, M., Schneider, W. and Schlag, P.M.
Onkologie 31
(4): 166-172.
April 2008
Long-lasting remission of pulmonary metastases of renal cell cancer under IFN-beta therapy in a patient with multiple sclerosis.
Floercken, A., Denecke, T., Kretzschmar, A., Gollasch, H., Reich, G. and Westermann, J.
Onkologie 29
: 382-384.
September 2006
Prognostic value of multimarker analysis in stage III colorectal cancer: one step forward towards an individualized therapy decision.
Grabowski, P., Maaser, K., Hanski, C., Stein, H., Sturm, I., Hopfenmueller, W., Doerken, B., Buhr, H.J., Zeitz, M. and Scheruebl, H.
Onkologie 28
(8-9): 399-403.
1 August 2005
Panhypopituitarism in a patient with breast cancer.
Sturm, I., Kirschke, S., Krahl, D. and Doerken, B.
Onkologie 27
: 480-482.
1 January 2004
Sentinel node biopsy in anal cancer - a promising strategy to individualize therapy.
Ulmer, C., Bembenek, A., Gretschel, S., Markwardt, J., Koswig, S., Slisow, W., Schneider, U. and Schlag, P.M.
Onkologie 26
(5): 456-460.
October 2003
Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
Thuss-Patience, P.C., Kretzschmar, A., Krenn, V., Doerken, B. and Reichardt, P.
Onkologie 26
(1): 63-65.
1 February 2003
Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis.
Reichardt, P., Pink, D., Tilgner, J., Kretzschmar, A., Thuss-Patience, P.C. and Doerken, B.
Onkologie 25
(6): 541-546.
1 December 2002
Hemangiosarcoma of the bone. Problems arising from the heterogeneity of malignant vascular tumors of the bone.
Krause, M., Tunn, P.U. and Schneider, U.
Onkologie 24
: 486-489.
1 October 2001
Oral trofosfamide in elderly and/or heavily pretreated patients with metastatic lung cancer.
Horvath, V., Hartlapp, J.H., Hegewisch-Becker, S., Feyerabend, T., von Weikersthal, L.F., Illiger, H.J., Jaeger, E., Peters, S.O., Reichardt, P., Uthgenannt, D., Weber, K., Wagner, T., Wiedemann, G.J. and Zschaber, R.
Onkologie 23
: 341-344.
1 August 2000
Irinotecan in esophageal cancer: First results.
Reichardt, P.
Onkologie 23 Suppl. 4
: 26-28.
1 April 2000
Two oral trofosfamide schedules in elderly patients with refractory non-Hodgkin's lymphoma.
Wiedemann, G.J., Zschaber, R., Hegewisch-Becker, S., Reichardt, P., Weber, K., Uthgenannt, D., Loewenstrom, O., Jaeger, E., Freund, M., Seeger, R., Feller, A.C., Merz, H., Hartlapp, J.H., Wagner, T. and Illiger, H.J.
Onkologie 22
: 134-138.
1 April 1999
Hyperthermic radiochemotherapy for esophageal cancer - Rationale and concept of a phase III trial.
Schlag, P.M., Benhidjeb, T. and Budach, V.
Onkologie 22
: 48-52.
1 February 1999
The importance of staging laparoscopy for the treatment of gastric cancer.
Schlag, P.M., Huenerbein, M. and Rau, B.
Onkologie 21
: 486-491.
1 January 1998
Intrapericardial application of mitoxantrone for treatment of malignant pericardial effusion.
Lentzsch, S., Reichardt, P., Guertler, R. and Doerken, B.
Onkologie 17
: 504-507.
1 January 1995
Malignant fibrous histiocytoma of bone and soft tissue: two different tumour entities? A retrospective study of 45 cases.
Mau, H., Ewerbeck, V., Reichardt, P., Bernd, L. and Sabo, D.
Onkologie 18
(6): 573-579.
1 January 1995
Frueherkennung von Krebs mit Hilfe von molekularbiologischen Markern.
Schlag, P.M. and Finke, L.H.
Onkologie 18
(Sonderheft): 2-7.
1 January 1995
Frueherkennung von Weichgewebs- und Extremitaetentumoren.
Tunn, P.U. and Schlag, P.M.
Onkologie 18
(Sonderheft): 61-63.
1 January 1995
A novel regimen for consolidation chemotherapy in adult acute myeloid leukemia in first remission.
Maschmeyer, G., Buechner, T., Hiddemann, W., Gassmann, W., Heinecke, A., Sauerland, M.C., Loeffler, H. and Heit, W.
Onkologie 17
: 62-65.
1 January 1994
Meningeal involvement in acute-leukemia and high-grade non-hodgkin's-lymphoma is associated with elevated activities of galactosyltransferases in the cerebrospinal-fluid.
Ottinger, H., Cyrus, C., Belka, C., Leuner, S., Engelhard, M., Augener, W. and Brittinger, G.
Onkologie 17
: 180-183.
1 January 1994
GM-CSF multiple course priming and long-term administration in newly diagnosed acute myeloid leukemia: comparison of three different GM-CSF routes and schedules with no GM-CSF.
Rottmann, R., Buechner, T., Hiddemann, W., Woermann, B., Maschmeyer, G., Ludwig, W.D. and Zuehlsdorf, M.
Onkologie 17
: 58-61.
1 January 1994
Pharmakocinetics of doxorubicin in the heparinized perfusate during isolated hyperthermic limb perfusion.
Kraus, T., Mross, K., Hamm, K., Kettelhack, C., Hossfeld, D.K. and Schlag, P.M.
Onkologie 16
: 16-21.
1 January 1993
Adjuvant beta-interferon therapy for gastric cancer - a randomized pilot study.
Buhl, K., Schlag, P.M., Linder, M.M., Geiger, G., Herfarth, C. and Trede, M.
Onkologie 15
: 300-304.
1 January 1992
Regional adoptive immunotherapy with IL-2 and LAK-Cells for liver metastases.
Keilholz, U., Scheibenbogen, C., Schlag, P.M., Goerich, J., Kauffmann, G.W., Tilgen, W. and Hunstein, W.
Onkologie 15
: 22-22.
1 January 1992
The influence of interleukin-2 or lymphokin-activated killer cells on normal hematopoietic stem cells.
Schulze, E., Burdach, S., Koerner, I.J., Federbusch, J., Hoffmann, U., Leiblein, S., Krahl, R. and Helbig, W.
Onkologie 15
: 245-253.
1 January 1992
Review
New concepts of staging in gastrointestinal tumors as a basis of diagnosis and multimodal therapy.
Gretschel, S., Moesta, K.T., Huenerbein, M., Lange, T., Gebauer, B., Stroszczinski, C., Bembenek, A. and Schlag, P.M.
Onkologie 27
(1): 23-30.
February 2004
Clinical research and industrial sponsoring: avenues towards transparency and credibility.
Hildebrandt, M. and Ludwig, W.D.
Onkologie 26
: 529-534.
1 December 2003
Sentinel lymphonodectomy in gastrointestinal cancer - where are we now?
Bembenek, A., Bayraktar, S., Gretschel, S., Ulmer, C., Schulze, T., Markwardt, J., Schneider, U., Huenerbein, M. and Schlag, P.M.
Onkologie 25
(4): 334-340.
August 2002
Surgical oncology in the interplay of surgical and nonsurgical disciplines.
Schlag, P.M., Liebeskind, U., Bembenek, A., Slisow, W., Benhidjeb, T., Kettelhack, C. and Tunn, P.U.
Onkologie 25
(4): 309-316.
August 2002
Assessment of quality of life in cancer patients: complexity, criticism, challenges.
Grumann, M. and Schlag, P.M.
Onkologie 24
(1): 10-15.
February 2001
Postoperative follow-up for colorectal cancer - What is left?
Schlag, P.M., Liebeskind, U. and Gutz, H.J.
Onkologie 23
: 202-206.
1 June 2000
Surgical and multimodality treatment of colorectal liver metastases.
Schlag, P.M., Benhidjeb, T. and Kilpert, B.
Onkologie 22
: 92-97.
1 April 1999
Integrins and e-cadherin expression: a way for the better understanding of the biological behaviour of colorectal cancer.
Terpe, H.J., Zoerb, C., Finke, L.H. and Schlag, P.M.
Onkologie 20
: 48-52.
1 January 1997
Advances for sphincter preservation in the surgical therapy of rectal cancer.
Schlag, P.M.
Onkologie 19
: 394-397.
1 January 1996
Contribution of molecular genetic changes for improved management of breast cancer.
Scherneck, S.
Onkologie 18
: 189-201.
1 January 1995
Isolated limb perfusion with tumor necrosis factor and melphalan - a new method in the treatment of regional melanoma metastases and locally advanced soft-tissue sarcoma.
Schlag, P.M. and Kettelhack, C.
Onkologie 18
: 123-125.
1 January 1995
Male breast cancer.
Schoen, M., Zaiac, M. and Schlag, P.M.
Onkologie 18
(1): 16-21.
1 January 1995
Impact of CEA determinations as an indicator for adjuvant treatment of colorectal cancer.
Vogel, T., Hohenberger, P. and Schlag, P.M.
Onkologie 18
(4): 334-338.
1 January 1995
Radio-thermotherapy in multimodal surgical treatment concepts.
Wust, P., Rau, B., Gremmler, M., Schlag, P.M., Jordan, A., Loeffel, J., Riess, H. and Felix, R.
Onkologie 18
: 110-121.
1 January 1995
Primary gastrointestinal lymphoma.
Huenerbein, M. and Schlag, P.M.
Onkologie 17
: 384-389.
1 January 1994
Diagnostic and operative laparoscopy in oncology.
Schlag, P.M., Huenerbein, M. and Rau, B.
Onkologie 17
: 226-232.
1 January 1994
Endoluminal and intraoperative ultrasound.
Kleinau, H., Liebeskind, U., Zaiac, M. and Schlag, P.M.
Onkologie 16
: 425-432.
1 January 1993
The role of intraoperative radiotherapy in the management of gastric cancer.
Eble, M.J., Hensley, F.W., Schlag, P.M., Herfarth, C. and Wannenmacher, M.
Onkologie 15
: 92-101.
1 January 1992
Indications, results and prospects of photodynamic therapy in the treatment of gastrointestinal and genitourinary cancer.
Huenerbein, M., Schlag, P.M., Stern, J., Gahlen, J. and Graschew, G.
Onkologie 15
: 115-122.
1 January 1992
Editorial
Limited surgery in early gastric cancer.
Gretschel, S. and Schlag, P.M.
Onkologie 28
: 243-244.
1 January 2005
Time for progress.
Adler, G. and Schlag, P.M.
Onkologie 27
(1): 11.
February 2004
Do we need surgical oncologists?
Schlag, P.M.
Onkologie 25
(4): 306-307.
August 2002
Minimal access surgery for cancer treatment.
Schlag, P.M. and Huenerbein, M.
Onkologie 25
(1): 72-73.
February 2002
P-glycoprotein turned twenty: Are we any closer to fight drug resistance in cancer?
Stein, U.
Onkologie 23
: 316-317.
1 August 2000
On the threshold of a new medicine.
Schlag, P.M.
Onkologie 20
: 8.
1 January 1997
Organ preservation in malignant tumors - the continuing challenge.
Schlag, P.M.
Onkologie 19
: 208.
1 January 1996
Gastric cancer - looking for therapeutic advancement.
Schlag, P.M.
Onkologie 15
: 82-83.
1 January 1992
This list was generated on Sat Dec 21 17:02:32 2024 UTC.